Literature DB >> 9716585

Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent.

K L Anderson1, K A Smith, F Pio, B E Torbett, R A Maki.   

Abstract

PU.1 is an ets family transcription factor that is expressed specifically in hematopoietic lineages. Through gene disruption studies in mice we have previously shown that the expression of PU.1 is not essential for early myeloid lineage or neutrophil commitment, but is essential for monocyte/macrophage development. We have also shown that PU.1-null (deficient) neutrophils have neutrophil morphology and express neutrophil-specific markers such as Gr-1 and chloroacetate esterase both in vivo and in vitro. We now demonstrate that although PU.1-null mice develop neutrophils, these cells fail to terminally differentiate as shown by the absence of messages for neutrophil secondary granule components and the absence or deficiency of cellular responses to stimuli that normally invoke neutrophil function. Specifically, PU.1-deficient neutrophils fail to respond to selected chemokines, do not generate superoxide ions, and are ineffective at bacterial uptake and killing. The failure to produce superoxide could, in part, be explained by the absence of the gp91 subunit of nicotinamide adenine dinucleotide phosphate oxidase, as shown by our inability to detect messages for the gp91(phox) gene. Incomplete maturation of PU.1-deficient neutrophils is cell autonomous and persists in cultured PU.1-deficient cells. Our results indicate that PU.1 is not necessary for neutrophil lineage commitment but is essential for normal development, maturation, and function of neutrophils. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716585

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Functional PU.1 in macrophages has a pivotal role in NF-κB activation and neutrophilic lung inflammation during endotoxemia.

Authors:  Manjula Karpurapu; Xuerong Wang; Jing Deng; Hyesuk Park; Lei Xiao; Ruxana T Sadikot; Randall S Frey; Ulrich A Maus; Gye Young Park; Edward W Scott; John W Christman
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

Review 2.  Transcriptional regulation of myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

3.  PRAM-1 is required for optimal integrin-dependent neutrophil function.

Authors:  Regina A Clemens; Sally A Newbrough; Elaine Y Chung; Shereen Gheith; Andrew L Singer; Gary A Koretzky; Erik J Peterson
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.

Authors:  Donald Metcalf; Aleksandar Dakic; Sandra Mifsud; Ladina Di Rago; Li Wu; Stephen Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  Neutrophils clear bacteria associated with parasitic nematodes augmenting the development of an effective Th2-type response.

Authors:  John T Pesce; Zhugong Liu; Hossein Hamed; Farhang Alem; Jeanette Whitmire; Hongxia Lin; Qian Liu; Joseph F Urban; William C Gause
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

Review 7.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 8.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

9.  IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation.

Authors:  Shirong Li; Jing Fu; Hui Wang; Huihui Ma; Xiaoming Xu; Yong-Guang Yang; Shixian Deng; Markus Y Mapara; Suzanne Lentzsch
Journal:  Blood Adv       Date:  2018-03-13

10.  Cooperative Activity of GABP with PU.1 or C/EBPε Regulates Lamin B Receptor Gene Expression, Implicating Their Roles in Granulocyte Nuclear Maturation.

Authors:  Krishnakumar Malu; Rahul Garhwal; Margery G H Pelletier; Deepali Gotur; Stephanie Halene; Monika Zwerger; Zhong-Fa Yang; Alan G Rosmarin; Peter Gaines
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.